SelectEvidenceTM: Complete Cybersecurity Medical Device Risk Assessment Platform
Transform the way you carry out risk assessments for your connected medical devices.

Centralized Cybersecurity Risk Management
SelectEvidenceTM is an expert cybersecurity risk assessment platform that guides medical device manufacturers through the process of identifying applicable vulnerabilities and identifying the right security controls to mitigate those risks. It provides device manufacturers with an intelligent, automated, and traceable approach to cybersecurity assessments, saving you time and money.

Accelerated Analysis
Proprietary algorithms inform
accelerated analysis, greatly
cutting the time needed to
manage risk.

Decision Support
For every vulnerability identified,
specific and actionable
suggested mitigations are
provided.

Continuous Monitoring
& Alerts
Scanning over 180K
vulnerabilities in real-time,
harnessing automation for
24/7 peace of mind.

Enterprise Level Reporting
Multi-level access and
reporting available for
compliance transparency
and visibility.

Standards-Based
Linked to industry standards,
leverage key repositories
for controls threats and
vulnerabilities.

Auto-Ingest SBOMs
Simple and automated ingestion
of each SBOM makes it easy
and fast to start monitoring
and managing risk.

Accelerate
Premarket cybersecurity risk analysis

Save Time
Postmarket continuously monitoring vulnerabilities

Leveraging SelectEvidenceTM as an integral part of your product development lifecycle for security risk assessment ensures your connected medical devices meet EU and FDA Premarket Submission and Postmarket Management guidelines.
List vulnerabilities, evaluate threats
When we evaluate the risks related to a particular medical device, SelectEvidenceTM lists vulnerabilities and sorts them into high, medium, and low categories, making it easy to prioritize the work needed.
Once a vulnerability has been managed, the risk score displayed on the dashboard is reduced. Each product has a graph that tracks acceptable and current risk levels, which will adjust in real-time as each vulnerability is identified and handled.
As you mitigate threats and vulnerabilities, your overall risk score improves. The platform evaluates risks and also guides you through the process of mitigating those risks by way of security controls.
SelectEvidenceTM not only identifies known vulnerabilities, it also enables you to manually upload outputs from in-house testing tools, including pen tests and static analysis tests.
Claim Your Free Trial
Nova Leah has developed a simple, clear-cut, free trial process.
Discover how SelectEvidenceTM can transform your risk management processes with an intelligent, standardized, repeatable, and traceable approach to implementing cybersecurity requirements across all your connected medical devices.
Step one: Learn how to use the platform with a detailed product demo
Step two: Start your free five-day evaluation mapped to your specific success criteria
Step three: Integrate SelectEvidenceTM into your product development lifecycle and enjoy the benefits!
Step one: Learn how to use the platform with a detailed product demo
Step two: Start your free five-day evaluation mapped to your specific success criteria
Step three: Integrate SelectEvidenceTM into your product development lifecycle and enjoy the benefits!
We’d Love to Talk!
Our friendly team of experts are here to help. If you’d like to find out more about SelectEvidenceTM let’s talk!
As Seen In





Nova Leah
Nova Leah is a world leader in the provision of cybersecurity solutions for medical device manufacturers and healthcare providers. With operations in the US and in Ireland, Nova Leah’s software helps connected medical device manufacturers meet cybersecurity compliance requirements throughout the entire product lifecycle.